Keywords: elan, top, product, line, sales, up, 1st
Elan's top 10 product line sales up 70% in 1st qtr, but results disappoint
Article | 13 May 2002
Ireland-based Elan Corp has reported total revenues of $443.6 millionfor first-quarter 2002, an increase of 3.3%. Within this, product sales rose 1.9% to $330.4 million ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
